Data d'inici: 01/07/2023
Data fi: 30/06/2027
Codi Projecte: A4312_13207
Acrònim: Vax2Muc - Fase 2
Vax2Muc will deliver (i) en prophylactic vaccine candidate against H. pylori as PoC, and (ii) a wealth of
knowledge and technologys that can be translated into clinic development pipeline and e broadly applicable for various GI/AMR mucosal pathogens to significantly benefit la challenging field of mucosal vacunation and finally reduce disease burden from
AMR/GI diseases.
